5th Circuit Bans Mifepristone Mail Distribution; Drugmakers Rush to Supreme CourtMay 16, 2026Legal NewsThe Fifth Circuit voided FDA's 2021 mail-dispensing rule for mifepristone, banning telehealth prescribing nationwide. The Supreme Court issued an emergency stay May 14.
Fifth Circuit Blocks Mifepristone Mail Access, Drugmakers Rush to Supreme CourtMay 14, 2026Legal NewsThe Fifth Circuit ordered the FDA to reinstate in-person dispensing rules for mifepristone, blocking mail and telehealth access nationally. Drugmakers filed emergency Supreme Court applications.